| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.87▲ | 8.87▲ | 8.92▲ | 9.08▼ | 8.78▲ |
| MA10 | 8.83▲ | 8.97▼ | 9.17▼ | 8.30▲ | 10.11▼ |
| MA20 | 8.84▲ | 9.17▼ | 9.26▼ | 8.65▲ | 11.12▼ |
| MA50 | 8.94▼ | 9.19▼ | 8.50▲ | 10.48▼ | 10.38▼ |
| MA100 | 9.16▼ | 8.38▲ | 8.52▲ | 11.27▼ | 9.19▼ |
| MA200 | 9.24▼ | 8.56▲ | 9.36▼ | 10.98▼ | 6.92▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | -0.055▼ | -0.113▼ | 0.235▲ | -0.505▼ |
| RSI | 56.273▲ | 43.898▼ | 48.623▼ | 47.184▼ | 40.438▼ |
| STOCH | 83.961▲ | 11.863▼ | 16.639▼ | 76.679 | 14.497▼ |
| WILL %R | -8.511▲ | -76.243▼ | -76.243▼ | -23.211▲ | -73.458 |
| CCI | 181.471▲ | -73.064 | -106.221▼ | 45.440 | -92.244 |
|
Wednesday, February 11, 2026 03:58 AM
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, February 04, 2026 03:30 AM
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So it works quite well as a VEGFR inhibitor and it is de-risked in that sense.
|
|
Monday, January 26, 2026 04:00 PM
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Ocular Therapeutix ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 9.50 | 9.58 | 8.72 | 8.94 | 5,496,537 |
| 26/02/26 | 9.41 | 9.63 | 8.91 | 9.59 | 8,040,500 |
| 25/02/26 | 9.32 | 9.7591 | 9.255 | 9.50 | 7,780,092 |
| 24/02/26 | 8.45 | 8.99 | 8.43 | 8.955 | 6,238,705 |
| 23/02/26 | 7.76 | 8.445 | 7.695 | 8.41 | 0 |
| 20/02/26 | 6.99 | 8.00 | 6.985 | 7.78 | 13,003,872 |
| 19/02/26 | 6.90 | 7.34 | 6.85 | 7.03 | 9,715,433 |
| 18/02/26 | 7.06 | 7.24 | 6.775 | 6.88 | 11,558,121 |
| 17/02/26 | 6.41 | 7.13 | 6.2301 | 6.99 | 51,578,447 |
| 13/02/26 | 9.19 | 9.34 | 8.83 | 8.88 | 3,831,938 |
|
|
||||
|
|
||||
|
|